Postural Low Back Pain
2
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Ache Laboratorios FarmaceuticosBrazil - Anápolis
2 programs2
Orphenadrine + Acetaminophen + Caffeine + Diclofenac SodiumPhase 3
orphenadrine, acetaminophen, caffeine and diclofenac sodiumPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Ache Laboratorios Farmaceuticosorphenadrine, acetaminophen, caffeine and diclofenac sodium
Clinical Trials (1)
Total enrollment: 110 patients across 1 trials
NCT02985671Ache Laboratorios Farmaceuticosorphenadrine, acetaminophen, caffeine and diclofenac sodium
To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.
Start: Jan 2021Est. completion: Oct 2021110 patients
Phase 3Unknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.